Leadership Overview
Abdi İbrahim İlaç has 4 executives leading key functions including financial oversight, country-level fiscal management, human resources, and manufacturing operations.
Committed to advancing global health standards, Abdi İbrahim İlaç delivers essential pharmaceutical solutions while maintaining a legacy of excellence in the healthcare sector through innovation and sustainable production practices.
Committed to advancing global health standards, Abdi İbrahim İlaç delivers essential pharmaceutical solutions while maintaining a legacy of excellence in the healthcare sector through innovation and sustainable production practices.
Leadership Roles at Abdi İbrahim İlaç
Gülçin Oğuz - Chief Financial Officer Asistanı
Gülçin Oğuz, the Chief Financial Officer Asistanı at Abdi İbrahim İlaç, supports the execution of complex fiscal strategies across the organization. By managing critical financial data and coordinating reporting cycles, the Chief Financial Officer Asistanı ensures the accuracy of budgetary allocations. This role involves close collaboration with senior leadership to monitor liquidity and optimize capital distribution for pharmaceutical research. Gülçin Oğuz maintains rigorous oversight of internal audit processes, facilitating transparency in all fiscal operations. Through the analysis of market trends, the Chief Financial Officer Asistanı provides actionable insights that drive long-term financial stability. By streamlining administrative workflows within the finance department, the position enhances overall operational efficiency. This leadership function remains vital for maintaining the fiscal health of the company while supporting the broader mission of delivering high-quality healthcare products to the global market.
Mazhar Çavdar - Chief Financial Officer, Country
Mazhar Çavdar, the Chief Financial Officer, Country at Abdi İbrahim İlaç, directs the comprehensive financial strategy for regional operations. Overseeing fiscal planning and risk management, the Chief Financial Officer, Country ensures alignment with corporate growth objectives. This role involves managing complex tax structures and regulatory compliance across diverse markets. Mazhar Çavdar architects robust financial frameworks that support the expansion of pharmaceutical manufacturing capabilities. By evaluating investment opportunities and monitoring cash flow, the Chief Financial Officer, Country secures the necessary resources for ongoing research and development initiatives. The position requires constant interaction with the Board to report on regional performance metrics and profitability targets. Through disciplined capital management, the Chief Financial Officer, Country strengthens the competitive position of the company within the healthcare sector, ensuring sustainable revenue generation and long-term value creation for all stakeholders involved in the pharmaceutical supply chain.
M. Oğuzcan - President, Human Resources, Communications & Sustainability
M. Oğuzcan, the President, Human Resources, Communications & Sustainability at Abdi İbrahim İlaç, drives the organizational culture and corporate social responsibility initiatives. Overseeing talent acquisition and employee development, the President, Human Resources, Communications & Sustainability fosters a high-performance environment essential for pharmaceutical innovation. This role involves architecting internal communication strategies that align the workforce with the core mission of improving public health. M. Oğuzcan manages sustainability programs that reduce the environmental footprint of manufacturing processes, ensuring compliance with global standards. By integrating human capital management with corporate communications, the President, Human Resources, Communications & Sustainability enhances the reputation of the company among healthcare professionals and the public. This leadership position supports the strategic goals of the organization by cultivating a diverse and skilled workforce. Through these efforts, the President, Human Resources, Communications & Sustainability ensures that the company remains a leader in ethical and sustainable pharmaceutical practices.
Caner Kilincer - President, Manufacturing & Supply
Caner Kilincer, the President, Manufacturing & Supply at Abdi İbrahim İlaç, directs the end-to-end production and distribution of pharmaceutical products. Overseeing large-scale manufacturing facilities, the President, Manufacturing & Supply ensures that all operations meet stringent quality and safety standards. This role involves optimizing supply chain logistics to maintain consistent product availability across regional markets. Caner Kilincer architects efficient production workflows that leverage advanced technology to increase output while minimizing waste. By coordinating with procurement and quality assurance teams, the President, Manufacturing & Supply guarantees the integrity of the pharmaceutical supply chain. This leadership function supports the growth of the company by ensuring that manufacturing capacity aligns with market demand. Through the implementation of lean manufacturing principles, the President, Manufacturing & Supply drives operational excellence and cost-effectiveness. These efforts remain critical for delivering life-saving medications to patients and maintaining the reputation of the company as a reliable provider in the healthcare sector.
Explore Leadership Teams in Manufacturing
Sanofi is a global biopharmaceutical company dedicated to improving lives through scientific innovation. The company focuses on discovering, developing, and delivering medicines and vaccines across immunology, rare diseases, neurology, oncology, and preventive care. Guided by research and patient needs, it works with healthcare partners worldwide to advance sustainable and responsible healthcare solutions.
Company Leadership PT
WS
PCI Pharma Services is an integrated full service provider to companies in the global healthcare industry. They offer services including analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, storage, and distribution. They are headquartered in Philadelphia, Pennsylvania with locations in the United States and Europe.
Company Leadership BP
HL
BK
Founded in 1947 and headquartered in Mumbai, Indoco Remedies Limited is a fully integrated, research-oriented pharma company. Indoco specializes in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Company Leadership
PA
AR
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Company Leadership SP
CS
NB
RI
Frequently Asked Questions Regarding Abdi İbrahim İlaç Top Executives and Leadership Team
